Matsubara, Shiro https://orcid.org/0000-0002-2519-5700
Seki, Morinobu
Suzuki, Shigeaki
Komori, Takashi
Takamori, Mikio
Article History
Received: 14 May 2019
Accepted: 11 September 2019
First Online: 18 September 2019
Consent for publication
: All authors contributed to this study, read the final version of this manuscript and approved its publication.
: The authors have no conflicting interest regarding the present study except Dr. Suzuki who is a consultant/advisory board member on neurologic side effects for Ono Pharmaceutical Company, Bristol-Myers Squibb and MSD.